Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

Young Kwang Chae*, Ayush Arya, Wade Iams, Marcelo R. Cruz, Sunandana Chandra, Jaehyuk Choi, Francis Giles

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

138 Scopus citations

Fingerprint

Dive into the research topics of 'Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.

Medicine & Life Sciences